Novel Coronavirus (SARS-CoV-2/COVID-19)
Data from the nation’s initial set of patients receiving COVID-19 booster shots found similar rates and types of adverse reactions, such as pain at the injection site, headache or fatigue, according to a Centers for Disease Control and Prevention study.
The White House Office of the United States Trade Representative extended through Nov. 14 tariff exemptions for certain medical care products needed to address the COVID-19 pandemic while it considers “further extensions and/or modifications as appropriate."
The Honorable Chiquita Brooks-LaSure
Administrator
Centers for Medicare & Medicaid Services
7500 Security Blvd
Baltimore, MD 21244
RE: Forthcoming Interim Final Rule Implementing a Mandatory COVID-19 Vaccination Policy for Hospitals and Other Health Care Providers Participating in Medicare and…
Commenting on a forthcoming Centers for Medicare & Medicaid Services’ rule requiring COVID-19 vaccinations for workers in most health care settings receiving Medicare or Medicaid reimbursement, AHA urged the agency to include appropriate safeguards to preserve access to care in all communities…
On this episode, I discuss emergency preparedness, caregiver resiliency and health equity — all through the lens of the COVID-19 pandemic — with Fritz Francois, M.D., chief medical officer and patient safety officer at New York University Langone Health and a professor at NYU Grossman School of…
AHA urged the Office of the United States Trade Representative to extend the current Section 301 tariff exemptions for certain medical devices to ensure hospitals and health systems have the supplies they need to continue to safely and effectively care for all patients. Without an extension, the…
The AHA urged the Health Resources and Services Administration to quickly distribute the $17 billion in Phase 4 provider relief funds and $8.5 billion in American Rescue Plan Act funds for rural providers, as well as reverse a new requirement that capital projects be fully completed before the…
AHA response to comments on certain product exclusions related to COVID-19.
The optimism of early summer that we were turning the corner on COVID-19 has been replaced with hard reality. The pandemic will be with us for the foreseeable future, affecting not only our nation’s health, but also hospitals’ and health systems’ ability to improve it.
The FDA and CDC’s recent booster shot policy decisions are important steps toward ending COVID-19. The FDA and CDC’s review further confirms the safety and efficacy of the COVID-19 vaccines, and underscores why hospitals and health systems have worked so hard to vaccinate their staff and…